Logo image of BC8.DE

BECHTLE AG (BC8.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:BC8 - DE0005158703 - Common Stock

43.68 EUR
+0.28 (+0.65%)
Last: 12/30/2025, 7:00:00 PM
Fundamental Rating

5

BC8 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 68 industry peers in the IT Services industry. BC8 has an excellent financial health rating, but there are some minor concerns on its profitability. While showing a medium growth rate, BC8 is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year BC8 was profitable.
In the past year BC8 had a positive cash flow from operations.
BC8 had positive earnings in each of the past 5 years.
BC8 had a positive operating cash flow in each of the past 5 years.
BC8.DE Yearly Net Income VS EBIT VS OCF VS FCFBC8.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

1.2 Ratios

BC8 has a Return On Assets (5.25%) which is comparable to the rest of the industry.
BC8 has a Return On Equity (10.97%) which is in line with its industry peers.
BC8 has a Return On Invested Capital (8.29%) which is in line with its industry peers.
BC8 had an Average Return On Invested Capital over the past 3 years of 12.02%. This is in line with the industry average of 11.04%.
Industry RankSector Rank
ROA 5.25%
ROE 10.97%
ROIC 8.29%
ROA(3y)6.7%
ROA(5y)6.98%
ROE(3y)14.8%
ROE(5y)15.62%
ROIC(3y)12.02%
ROIC(5y)11.98%
BC8.DE Yearly ROA, ROE, ROICBC8.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

BC8 has a Profit Margin (3.39%) which is in line with its industry peers.
BC8's Profit Margin has improved in the last couple of years.
The Operating Margin of BC8 (4.89%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of BC8 has grown nicely.
With a Gross Margin value of 18.07%, BC8 is not doing good in the industry: 80.88% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of BC8 has grown nicely.
Industry RankSector Rank
OM 4.89%
PM (TTM) 3.39%
GM 18.07%
OM growth 3Y0.2%
OM growth 5Y6.64%
PM growth 3Y-3.72%
PM growth 5Y4.18%
GM growth 3Y1.35%
GM growth 5Y4.79%
BC8.DE Yearly Profit, Operating, Gross MarginsBC8.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

7

2. Health

2.1 Basic Checks

BC8 has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, BC8 has about the same amount of shares outstanding.
The number of shares outstanding for BC8 remains at a similar level compared to 5 years ago.
The debt/assets ratio for BC8 has been reduced compared to a year ago.
BC8.DE Yearly Shares OutstandingBC8.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BC8.DE Yearly Total Debt VS Total AssetsBC8.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

BC8 has an Altman-Z score of 4.24. This indicates that BC8 is financially healthy and has little risk of bankruptcy at the moment.
BC8 has a better Altman-Z score (4.24) than 83.82% of its industry peers.
The Debt to FCF ratio of BC8 is 1.84, which is an excellent value as it means it would take BC8, only 1.84 years of fcf income to pay off all of its debts.
BC8 has a Debt to FCF ratio of 1.84. This is in the better half of the industry: BC8 outperforms 73.53% of its industry peers.
BC8 has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
BC8 has a Debt to Equity ratio of 0.21. This is in the better half of the industry: BC8 outperforms 70.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.84
Altman-Z 4.24
ROIC/WACC1.25
WACC6.63%
BC8.DE Yearly LT Debt VS Equity VS FCFBC8.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.68 indicates that BC8 should not have too much problems paying its short term obligations.
BC8 has a better Current ratio (1.68) than 76.47% of its industry peers.
BC8 has a Quick Ratio of 1.39. This is a normal value and indicates that BC8 is financially healthy and should not expect problems in meeting its short term obligations.
BC8 has a Quick ratio of 1.39. This is in the better half of the industry: BC8 outperforms 72.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1.39
BC8.DE Yearly Current Assets VS Current LiabilitesBC8.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

4

3. Growth

3.1 Past

The earnings per share for BC8 have decreased strongly by -14.07% in the last year.
Measured over the past 5 years, BC8 shows a small growth in Earnings Per Share. The EPS has been growing by 7.58% on average per year.
BC8 shows a decrease in Revenue. In the last year, the revenue decreased by -0.50%.
Measured over the past years, BC8 shows a small growth in Revenue. The Revenue has been growing by 3.25% on average per year.
EPS 1Y (TTM)-14.07%
EPS 3Y1.89%
EPS 5Y7.58%
EPS Q2Q%2.27%
Revenue 1Y (TTM)-0.5%
Revenue growth 3Y5.93%
Revenue growth 5Y3.25%
Sales Q2Q%5.09%

3.2 Future

Based on estimates for the next years, BC8 will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.43% on average per year.
The Revenue is expected to grow by 4.81% on average over the next years.
EPS Next Y-5.5%
EPS Next 2Y4.28%
EPS Next 3Y6.3%
EPS Next 5Y9.43%
Revenue Next Year1.7%
Revenue Next 2Y4.13%
Revenue Next 3Y5.02%
Revenue Next 5Y4.81%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BC8.DE Yearly Revenue VS EstimatesBC8.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
BC8.DE Yearly EPS VS EstimatesBC8.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 25.54, which means the current valuation is very expensive for BC8.
The rest of the industry has a similar Price/Earnings ratio as BC8.
The average S&P500 Price/Earnings ratio is at 26.51. BC8 is around the same levels.
With a Price/Forward Earnings ratio of 20.60, BC8 is valued on the expensive side.
BC8's Price/Forward Earnings ratio is in line with the industry average.
BC8 is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.54
Fwd PE 20.6
BC8.DE Price Earnings VS Forward Price EarningsBC8.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BC8 indicates a slightly more expensive valuation: BC8 is more expensive than 69.12% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BC8 is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 18.34
EV/EBITDA 11.72
BC8.DE Per share dataBC8.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)3.37
EPS Next 2Y4.28%
EPS Next 3Y6.3%

4

5. Dividend

5.1 Amount

BC8 has a Yearly Dividend Yield of 1.62%.
BC8's Dividend Yield is comparable with the industry average which is at 2.41.
Compared to an average S&P500 Dividend Yield of 2.00, BC8 has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.62%

5.2 History

On average, the dividend of BC8 grows each year by 16.00%, which is quite nice.
Dividend Growth(5Y)16%
Div Incr Years1
Div Non Decr Years6
BC8.DE Yearly Dividends per shareBC8.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

40.98% of the earnings are spent on dividend by BC8. This is a bit on the high side, but may be sustainable.
BC8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP40.98%
EPS Next 2Y4.28%
EPS Next 3Y6.3%
BC8.DE Yearly Income VS Free CF VS DividendBC8.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M
BC8.DE Dividend Payout.BC8.DE Dividend Payout, showing the Payout Ratio.BC8.DE Dividend Payout.PayoutRetained Earnings

BECHTLE AG

FRA:BC8 (12/30/2025, 7:00:00 PM)

43.68

+0.28 (+0.65%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-14 2025-11-14/bmo
Earnings (Next)03-20 2026-03-20/amc
Inst Owners38.25%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap5.50B
Revenue(TTM)6.35B
Net Income(TTM)215.25M
Analysts80
Price Target45.8 (4.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.62%
Yearly Dividend0.7
Dividend Growth(5Y)16%
DP40.98%
Div Incr Years1
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.1%
Min EPS beat(2)-5.27%
Max EPS beat(2)9.48%
EPS beat(4)1
Avg EPS beat(4)-1.86%
Min EPS beat(4)-9.37%
Max EPS beat(4)9.48%
EPS beat(8)2
Avg EPS beat(8)-3.08%
EPS beat(12)3
Avg EPS beat(12)-1.94%
EPS beat(16)6
Avg EPS beat(16)-0.67%
Revenue beat(2)1
Avg Revenue beat(2)-0.17%
Min Revenue beat(2)-1.25%
Max Revenue beat(2)0.9%
Revenue beat(4)1
Avg Revenue beat(4)-0.54%
Min Revenue beat(4)-1.25%
Max Revenue beat(4)0.9%
Revenue beat(8)3
Avg Revenue beat(8)-2.73%
Revenue beat(12)5
Avg Revenue beat(12)-0.16%
Revenue beat(16)7
Avg Revenue beat(16)-3.75%
PT rev (1m)2.15%
PT rev (3m)4.05%
EPS NQ rev (1m)2.88%
EPS NQ rev (3m)4.96%
EPS NY rev (1m)-0.31%
EPS NY rev (3m)-0.49%
Revenue NQ rev (1m)-0.21%
Revenue NQ rev (3m)-0.67%
Revenue NY rev (1m)-1.78%
Revenue NY rev (3m)-1.72%
Valuation
Industry RankSector Rank
PE 25.54
Fwd PE 20.6
P/S 0.87
P/FCF 18.34
P/OCF 13.17
P/B 2.81
P/tB 6.26
EV/EBITDA 11.72
EPS(TTM)1.71
EY3.91%
EPS(NY)2.12
Fwd EY4.86%
FCF(TTM)2.38
FCFY5.45%
OCF(TTM)3.32
OCFY7.59%
SpS50.42
BVpS15.57
TBVpS6.98
PEG (NY)N/A
PEG (5Y)3.37
Graham Number24.48
Profitability
Industry RankSector Rank
ROA 5.25%
ROE 10.97%
ROCE 11.68%
ROIC 8.29%
ROICexc 10.25%
ROICexgc 20.62%
OM 4.89%
PM (TTM) 3.39%
GM 18.07%
FCFM 4.72%
ROA(3y)6.7%
ROA(5y)6.98%
ROE(3y)14.8%
ROE(5y)15.62%
ROIC(3y)12.02%
ROIC(5y)11.98%
ROICexc(3y)15.84%
ROICexc(5y)15.71%
ROICexgc(3y)29.63%
ROICexgc(5y)28.23%
ROCE(3y)16.94%
ROCE(5y)16.89%
ROICexgc growth 3Y4.87%
ROICexgc growth 5Y7.72%
ROICexc growth 3Y-3.54%
ROICexc growth 5Y2.28%
OM growth 3Y0.2%
OM growth 5Y6.64%
PM growth 3Y-3.72%
PM growth 5Y4.18%
GM growth 3Y1.35%
GM growth 5Y4.79%
F-Score5
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.84
Debt/EBITDA 0.86
Cap/Depr 75.08%
Cap/Sales 1.85%
Interest Coverage 13.03
Cash Conversion 89.38%
Profit Quality 139.44%
Current Ratio 1.68
Quick Ratio 1.39
Altman-Z 4.24
F-Score5
WACC6.63%
ROIC/WACC1.25
Cap/Depr(3y)72%
Cap/Depr(5y)67.96%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.35%
Profit Quality(3y)113.31%
Profit Quality(5y)113.66%
High Growth Momentum
Growth
EPS 1Y (TTM)-14.07%
EPS 3Y1.89%
EPS 5Y7.58%
EPS Q2Q%2.27%
EPS Next Y-5.5%
EPS Next 2Y4.28%
EPS Next 3Y6.3%
EPS Next 5Y9.43%
Revenue 1Y (TTM)-0.5%
Revenue growth 3Y5.93%
Revenue growth 5Y3.25%
Sales Q2Q%5.09%
Revenue Next Year1.7%
Revenue Next 2Y4.13%
Revenue Next 3Y5.02%
Revenue Next 5Y4.81%
EBIT growth 1Y-13.29%
EBIT growth 3Y6.14%
EBIT growth 5Y10.1%
EBIT Next Year36.78%
EBIT Next 3Y17.89%
EBIT Next 5Y11.53%
FCF growth 1Y-31.78%
FCF growth 3Y27.55%
FCF growth 5Y27.87%
OCF growth 1Y-22.28%
OCF growth 3Y25.19%
OCF growth 5Y24.58%

BECHTLE AG / BC8.DE FAQ

Can you provide the ChartMill fundamental rating for BECHTLE AG?

ChartMill assigns a fundamental rating of 5 / 10 to BC8.DE.


What is the valuation status for BC8 stock?

ChartMill assigns a valuation rating of 2 / 10 to BECHTLE AG (BC8.DE). This can be considered as Overvalued.


How profitable is BECHTLE AG (BC8.DE) stock?

BECHTLE AG (BC8.DE) has a profitability rating of 5 / 10.


What is the valuation of BECHTLE AG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BECHTLE AG (BC8.DE) is 25.54 and the Price/Book (PB) ratio is 2.81.


Can you provide the financial health for BC8 stock?

The financial health rating of BECHTLE AG (BC8.DE) is 7 / 10.